Figure 3: The immunohistochemical study of cJNK( P55/P46)expression (western blot). Upper panel represents the western blotof the SAH only group (A), the SAH + vehicle group (B),500ug/kg/day parecoxib treatment SAH group (C), 1000ug/kg/dayparecoxib treatment in SAH rats (D) and SAH animals received2000ug/kg/day parecoxib treatment (E). Bar graphs revealed theassay showed induced cJNK immunoreactivity in the SAH groupswhen compared with the control group. Parecoxib dosedependentlyreduced the expression of cJNK when compared withthe SAH groups. Data in the figure are presented as mean ± SD.(*,**: P<0.01, #: P>0.01, indicates comparison among the 500, 1000,2000ug/kg parecoxib and SAH groups respectively. )